{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:23:50Z","timestamp":1791206630977,"version":"4.1.0"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The E\u03bc-myc transgenic mouse has provided a valuable model for the study of B-cell lymphoma. Making use of gene expression analysis and, in particular, expression signatures of cell signaling pathway activation, we now show that several forms of B lymphoma can be identified in the E\u03bc-myc mice associated with time of tumor onset. Furthermore, one form of E\u03bc-myc tumor with pre-B character is shown to resemble human Burkitt lymphoma, whereas others exhibit more differentiated B-cell characteristics and show similarity with human diffuse large B-cell lymphoma in the pattern of gene expression, as well as oncogenic pathway activation. Importantly, we show that signatures of oncogenic pathway activity provide further dissection of the spectrum of diffuse large B-cell lymphoma, identifying a subset of patients who have very poor prognosis and could benefit from more aggressive or novel therapeutic strategies. Taken together, these studies provide insight into the complexity of the oncogenic process and a novel strategy for dissecting the heterogeneity of B lymphoma. [Cancer Res 2008;68(20):8525\u201334]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-1329","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T10:52:27Z","timestamp":1224067947000},"page":"8525-8534","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the E\u03bc-\n                    <i>myc<\/i>\n                    Model and Human Diffuse Large B-Cell Lymphoma"],"prefix":"10.1158","volume":"68","author":[{"given":"Seiichi","family":"Mori","sequence":"first","affiliation":[{"name":"1Duke Institute for Genome Sciences and Policy; Departments of"},{"name":"2Molecular Genetics and Microbiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Rempel","sequence":"additional","affiliation":[{"name":"1Duke Institute for Genome Sciences and Policy; Departments of"},{"name":"2Molecular Genetics and Microbiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Chang","sequence":"additional","affiliation":[{"name":"1Duke Institute for Genome Sciences and Policy; Departments of"},{"name":"2Molecular Genetics and Microbiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yao","sequence":"additional","affiliation":[{"name":"1Duke Institute for Genome Sciences and Policy; Departments of"},{"name":"2Molecular Genetics and Microbiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand S.","family":"Lagoo","sequence":"additional","affiliation":[{"name":"3Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Potti","sequence":"additional","affiliation":[{"name":"1Duke Institute for Genome Sciences and Policy; Departments of"},{"name":"4Medicine, Duke University Medical Center, Durham, North Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bild","sequence":"additional","affiliation":[{"name":"1Duke Institute for Genome Sciences and Policy; Departments of"},{"name":"2Molecular Genetics and Microbiology,"},{"name":"5Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Nevins","sequence":"additional","affiliation":[{"name":"1Duke Institute for Genome Sciences and Policy; Departments of"},{"name":"2Molecular Genetics and Microbiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,10,15]]},"reference":[{"key":"2022061700264386900_B1","doi-asserted-by":"crossref","unstructured":"Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene\u20081999; 18: 3004\u201316.","DOI":"10.1038\/sj.onc.1202746"},{"key":"2022061700264386900_B2","doi-asserted-by":"crossref","unstructured":"Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability. Mol Cell\u20081999; 3: 169\u201379.","DOI":"10.1016\/S1097-2765(00)80308-1"},{"key":"2022061700264386900_B3","unstructured":"Jaffe ES, Harris NL, Stein HJ, Vardiman JW. Tumours of haematopoietic and lymphoid tissues. Lyon (France): IARC Press; 2001."},{"key":"2022061700264386900_B4","doi-asserted-by":"crossref","unstructured":"Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature\u20081985; 318: 533\u20138.","DOI":"10.1038\/318533a0"},{"key":"2022061700264386900_B5","doi-asserted-by":"crossref","unstructured":"Morse HC, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood\u20082002; 100: 246\u201358.","DOI":"10.1182\/blood.V100.1.246"},{"key":"2022061700264386900_B6","doi-asserted-by":"crossref","unstructured":"Harris AW, Pinkert CA, Crawford M, Langdon WY, Brinster RL, Adams JM. The E\u03bc-myc transgenic mouse. A model for high incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med\u20081988; 167: 353\u201371.","DOI":"10.1084\/jem.167.2.353"},{"key":"2022061700264386900_B7","doi-asserted-by":"crossref","unstructured":"Shaffer AL, Rosenwald A, Staudt, LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nature Rev\u20082002; 2: 920\u201332.","DOI":"10.1038\/nri953"},{"key":"2022061700264386900_B8","doi-asserted-by":"crossref","unstructured":"Kovalchuk AL, Qi CF, Torrey TA, et al. Burkitt lymphoma in the mouse. J Exp Med\u20082000; 192: 1183\u201390.","DOI":"10.1084\/jem.192.8.1183"},{"key":"2022061700264386900_B9","doi-asserted-by":"crossref","unstructured":"Zhu D, Qi CF, Morse HCI, Janz S, Stevenson FK. Deregulated expression of the Myc cellular oncogene drives development of mouse \u201cBurkitt-like\u201d lymphomas from naive B cells. Blood\u20082005; 105: 2135\u20137.","DOI":"10.1182\/blood-2004-07-2573"},{"key":"2022061700264386900_B10","doi-asserted-by":"crossref","unstructured":"Mori S, Inoshima K, Shima Y, Schmidt EV, Yokota Y, Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland. FEBS Lett\u20082003; 551: 123\u20137.","DOI":"10.1016\/S0014-5793(03)00906-2"},{"key":"2022061700264386900_B11","doi-asserted-by":"crossref","unstructured":"Huang E, Ishida S, Pittman J, Dressman H, West M, Nevins JR. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet\u20082003; 34: 226\u201330.","DOI":"10.1038\/ng1167"},{"key":"2022061700264386900_B12","doi-asserted-by":"crossref","unstructured":"Bild A, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature\u20082006; 439: 353\u20137.","DOI":"10.1038\/nature04296"},{"key":"2022061700264386900_B13","doi-asserted-by":"crossref","unstructured":"Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics\u20082006; 22: 2926\u201333.","DOI":"10.1093\/bioinformatics\/btl483"},{"key":"2022061700264386900_B14","doi-asserted-by":"crossref","unstructured":"Hoffmann R, Siedl T, Neeb M, Rolink A, Melchers F. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res\u20082002; 12: 98\u2013111.","DOI":"10.1101\/gr.201501"},{"key":"2022061700264386900_B15","doi-asserted-by":"crossref","unstructured":"Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C, Mathis D. Memory T, memory B. cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci U S A\u20082006; 103: 3304\u20139.","DOI":"10.1073\/pnas.0511137103"},{"key":"2022061700264386900_B16","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A\u20082003; 100: 2639\u201344.","DOI":"10.1073\/pnas.0437996100"},{"key":"2022061700264386900_B17","doi-asserted-by":"crossref","unstructured":"Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A. Reverse engineering of regulatory networks in human B cells. Nat Genet\u20082005; 37: 382\u201390.","DOI":"10.1038\/ng1532"},{"key":"2022061700264386900_B18","doi-asserted-by":"crossref","unstructured":"Potti A, Lancaster JM, Dressman HK, et al. A genomic strategy to guide the use of chemotherapeutic drugs in solid tumors. Nat Med\u20082006; 12: 1294\u2013300.","DOI":"10.1038\/nm1491"},{"key":"2022061700264386900_B19","doi-asserted-by":"crossref","unstructured":"Viemann D, Goebeler M, Schmid S, et al. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol\u20082006; 80: 174\u201385.","DOI":"10.1189\/jlb.0905530"},{"key":"2022061700264386900_B20","doi-asserted-by":"crossref","unstructured":"Tian B, Nowak DE, Jamaluddin M, Wang S, Brasier AR. Identification of direct genomic targets downstream of the nuclear factor-\u03baB transcription factor mediating tumor necrosis factor signaling. J Biol Chem\u20082005; 280: 17435\u201348.","DOI":"10.1074\/jbc.M500437200"},{"key":"2022061700264386900_B21","doi-asserted-by":"crossref","unstructured":"Tang Z, McGowan BS, Huber SA, et al. Gene expression profiling during the transition to failure in TNF-\u03b1 over-expressing mice demonstrates the development of autoimmune myocarditis. J Mol Cell Cardiol\u20082004; 36: 515\u201330.","DOI":"10.1016\/j.yjmcc.2004.01.008"},{"key":"2022061700264386900_B22","doi-asserted-by":"crossref","unstructured":"Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med\u20082006; 354: 2419\u201330.","DOI":"10.1056\/NEJMoa055351"},{"key":"2022061700264386900_B23","doi-asserted-by":"crossref","unstructured":"Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood\u20082005; 105: 1851\u201361.","DOI":"10.1182\/blood-2004-07-2947"},{"key":"2022061700264386900_B24","doi-asserted-by":"crossref","unstructured":"Leone G, Sears R, Huang E, et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell\u20082001; 8: 105\u201313.","DOI":"10.1016\/S1097-2765(01)00275-1"},{"key":"2022061700264386900_B25","doi-asserted-by":"crossref","unstructured":"D'Cruz CM, Gunther EJ, Boxer RB, et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med\u20082001; 7: 235\u20139.","DOI":"10.1038\/84691"},{"key":"2022061700264386900_B26","doi-asserted-by":"crossref","unstructured":"Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2\u201353 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev\u20081999; 13: 2658\u201369.","DOI":"10.1101\/gad.13.20.2658"},{"key":"2022061700264386900_B27","doi-asserted-by":"crossref","unstructured":"Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW. INK4a\/ARF mutations accelerate lymphomagenesis and promoter chemoresistance by disabling p53. Genes Dev\u20081999; 13: 2670\u20137.","DOI":"10.1101\/gad.13.20.2670"},{"key":"2022061700264386900_B28","unstructured":"Alexander WS, Bernard O, Cory S, Adams JM. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations. Oncogene\u20081989; 4: 575\u201381."},{"key":"2022061700264386900_B29","doi-asserted-by":"crossref","unstructured":"He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature\u20082005; 435: 828\u201333.","DOI":"10.1038\/nature03552"},{"key":"2022061700264386900_B30","doi-asserted-by":"crossref","unstructured":"Egle A, Harris AW, Bouillet P, Cory S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci U S A\u20082004; 101: 6164\u20139.","DOI":"10.1073\/pnas.0401471101"},{"key":"2022061700264386900_B31","unstructured":"Strasser A, Harris AW, Cory S. E mu-bcl-2 transgene facilities spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene\u20081993; 8: 1\u20139."},{"key":"2022061700264386900_B32","doi-asserted-by":"crossref","unstructured":"Scott CL, Schuler M, Marsden VS, et al. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation. J Cell Biol\u20082004; 164: 89\u201396.","DOI":"10.1083\/jcb.200310041"},{"key":"2022061700264386900_B33","doi-asserted-by":"crossref","unstructured":"Kelly PN, Puthalakath H, Adams JM, Strasser A. Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma. Blood\u20082007; 109: 4907\u201313.","DOI":"10.1182\/blood-2006-10-051847"},{"key":"2022061700264386900_B34","doi-asserted-by":"crossref","unstructured":"Wen R, Chen Y, Bai L, et al. Essential role of phospholipase C \u03b3 2 in early B-cell development and Myc-mediated lymphomagenesis. Mol Cell Biol\u20082006; 26: 9364\u201376.","DOI":"10.1128\/MCB.00839-06"},{"key":"2022061700264386900_B35","doi-asserted-by":"crossref","unstructured":"Keller U, Nilsson JA, Maclean KH, Old JB, Cleveland JL. Nfkb 1 is dispensable for Myc-induced lymphomagenesis. Oncogene\u20082005; 24: 6231\u201340.","DOI":"10.1038\/sj.onc.1208779"},{"key":"2022061700264386900_B36","doi-asserted-by":"crossref","unstructured":"Alt JR, Greiner TC, Cleveland JL, Eischen CM. Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J\u20082003; 22: 1442\u201350.","DOI":"10.1093\/emboj\/cdg133"},{"key":"2022061700264386900_B37","doi-asserted-by":"crossref","unstructured":"Baudino TA, Maclean KH, Brennan J, et al. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell\u20082003; 11: 905\u201314.","DOI":"10.1016\/S1097-2765(03)00102-3"},{"key":"2022061700264386900_B38","doi-asserted-by":"crossref","unstructured":"Schlee M, Holzel M, Bernard S, et al. C-myc activation impairs the NF-\u03baB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma. Int J Cancer\u20082007; 120: 1387\u201395.","DOI":"10.1002\/ijc.22372"},{"key":"2022061700264386900_B39","doi-asserted-by":"crossref","unstructured":"Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med\u20082006; 354: 2431\u201342.","DOI":"10.1056\/NEJMoa055759"},{"key":"2022061700264386900_B40","doi-asserted-by":"crossref","unstructured":"Ma C. Staudt LM. Molecular definition of the germinal centre stage of B-cell differentiation. Philos Trans R Soc Lond B Biol Sci\u20082001; 356: 83\u20139.","DOI":"10.1098\/rstb.2000.0752"},{"key":"2022061700264386900_B41","doi-asserted-by":"crossref","unstructured":"Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med\u20082002; 8: 68\u201374.","DOI":"10.1038\/nm0102-68"},{"key":"2022061700264386900_B42","doi-asserted-by":"crossref","unstructured":"Ganick DJ. Finlay JL. Acute lymphoblastic leukemia with Burkitt cell morphology and cytoplasmic immunoglobulin. Blood\u20081980; 56: 311\u20134.","DOI":"10.1182\/blood.V56.2.311.311"},{"key":"2022061700264386900_B43","doi-asserted-by":"crossref","unstructured":"Mangan KF, Rauch AE, Bishop M, Spiers AS, Lorch C, Scharfman WB. Acute lymphoblastic leukemia of Burkitt's type (L-3 ALL) lacking surface immunoglobulin and the 8;14 translocation. Am J Clin Pathol\u20081985; 83: 121\u20136.","DOI":"10.1093\/ajcp\/83.1.121"},{"key":"2022061700264386900_B44","unstructured":"Preud'homme JL, Dellagi K, Guglielmi P, et al. Immunologic markers of Burkitt's lymphoma cells. IARC Sci Publ\u20081985; 60: 47\u201364."},{"key":"2022061700264386900_B45","doi-asserted-by":"crossref","unstructured":"Melchers FB lymphocyte lineage cells from early precursors to Ig-secreting plasma cells: targets of regulation by the myc\/mad\/max families of genes? Curr Top Microbiol Immunol\u20081997; 224: 19\u201330.","DOI":"10.1007\/978-3-642-60801-8_2"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/20\/8525\/2596941\/8525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/20\/8525\/2596941\/8525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:39:39Z","timestamp":1655426379000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/20\/8525\/541404\/Utilization-of-Pathway-Signatures-to-Reveal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,15]]},"references-count":45,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2008,10,15]]},"published-print":{"date-parts":[[2008,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-1329","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1126845.583946","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22376640.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376637","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376637.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376634.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498285.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376634","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498285","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376640","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,15]]}}}